...
pcvx-img

Vaxcyte Inc, Common Stock

PCVX

NSQ

$109.15

-$1

(-0.91%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$12.29B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.39M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.97
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$44.2 L
$119.27 H
$109.15

About Vaxcyte Inc, Common Stock

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePCVXSectorS&P500
1-Week Return39.17%0.53%-1.09%
1-Month Return50.05%6.67%6.81%
3-Month Return53.86%7.92%4.49%
6-Month Return52.55%7.19%7.79%
1-Year Return114.02%18.48%22.93%
3-Year Return321.43%15.12%22.29%
5-Year Return317.4%73.77%88.01%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue1.23M1.41M1.80M9.20M10.17M[{"date":"2019-12-31","value":12.11,"profit":true},{"date":"2020-12-31","value":13.81,"profit":true},{"date":"2021-12-31","value":17.7,"profit":true},{"date":"2022-12-31","value":90.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(1.23M)(1.41M)(1.80M)(9.20M)(10.17M)[{"date":"2019-12-31","value":-123200000,"profit":false},{"date":"2020-12-31","value":-140500000,"profit":false},{"date":"2021-12-31","value":-180000000,"profit":false},{"date":"2022-12-31","value":-919600000,"profit":false},{"date":"2023-12-31","value":-1017100000,"profit":false}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses53.92M87.10M102.08M207.33M382.87M[{"date":"2019-12-31","value":14.08,"profit":true},{"date":"2020-12-31","value":22.75,"profit":true},{"date":"2021-12-31","value":26.66,"profit":true},{"date":"2022-12-31","value":54.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(54.15M)(89.58M)(103.67M)(232.26M)(393.04M)[{"date":"2019-12-31","value":-5415300000,"profit":false},{"date":"2020-12-31","value":-8958100000,"profit":false},{"date":"2021-12-31","value":-10367000000,"profit":false},{"date":"2022-12-31","value":-23225600000,"profit":false},{"date":"2023-12-31","value":-39304100000,"profit":false}]
Total Non-Operating Income/Expense4.47M601.00K3.93M17.13M53.68M[{"date":"2019-12-31","value":8.33,"profit":true},{"date":"2020-12-31","value":1.12,"profit":true},{"date":"2021-12-31","value":7.32,"profit":true},{"date":"2022-12-31","value":31.9,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(50.27M)(89.22M)(100.08M)(223.49M)(402.27M)[{"date":"2019-12-31","value":-5027400000,"profit":false},{"date":"2020-12-31","value":-8921700000,"profit":false},{"date":"2021-12-31","value":-10007700000,"profit":false},{"date":"2022-12-31","value":-22348500000,"profit":false},{"date":"2023-12-31","value":-40226600000,"profit":false}]
Income Taxes3.23M(1.40M)7.00K16.16M-[{"date":"2019-12-31","value":19.96,"profit":true},{"date":"2020-12-31","value":-8.65,"profit":false},{"date":"2021-12-31","value":0.04,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(53.50M)(87.82M)(100.08M)(239.64M)-[{"date":"2019-12-31","value":-5349900000,"profit":false},{"date":"2020-12-31","value":-8781900000,"profit":false},{"date":"2021-12-31","value":-10008400000,"profit":false},{"date":"2022-12-31","value":-23964000000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(50.27M)(89.22M)(100.08M)(223.49M)(402.27M)[{"date":"2019-12-31","value":-5027400000,"profit":false},{"date":"2020-12-31","value":-8921700000,"profit":false},{"date":"2021-12-31","value":-10007700000,"profit":false},{"date":"2022-12-31","value":-22348500000,"profit":false},{"date":"2023-12-31","value":-40226600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(53.50M)(87.82M)(100.08M)(239.64M)(402.27M)[{"date":"2019-12-31","value":-5349900000,"profit":false},{"date":"2020-12-31","value":-8781900000,"profit":false},{"date":"2021-12-31","value":-10008400000,"profit":false},{"date":"2022-12-31","value":-23964000000,"profit":false},{"date":"2023-12-31","value":-40226600000,"profit":false}]
EPS (Diluted)(1.08)(2.83)(1.93)(3.43)(4.13)[{"date":"2019-12-31","value":-108,"profit":false},{"date":"2020-12-31","value":-283,"profit":false},{"date":"2021-12-31","value":-193,"profit":false},{"date":"2022-12-31","value":-343,"profit":false},{"date":"2023-12-31","value":-413,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PCVX
Cash Ratio 17.53
Current Ratio 17.88

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PCVX
ROA (LTM) -20.10%
ROE (LTM) -29.08%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PCVX
Debt Ratio Lower is generally better. Negative is bad. 0.05
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.95

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PCVX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 4.54
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Vaxcyte Inc share price today?

Vaxcyte Inc (PCVX) share price today is $109.15

Can Indians buy Vaxcyte Inc shares?

Yes, Indians can buy shares of Vaxcyte Inc (PCVX) on Vested. To buy Vaxcyte Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PCVX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Vaxcyte Inc be purchased?

Yes, you can purchase fractional shares of Vaxcyte Inc (PCVX) via the Vested app. You can start investing in Vaxcyte Inc (PCVX) with a minimum investment of $1.

How to invest in Vaxcyte Inc shares from India?

You can invest in shares of Vaxcyte Inc (PCVX) via Vested in three simple steps:

  • Click on Sign Up or Invest in PCVX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Vaxcyte Inc shares
What is Vaxcyte Inc 52-week high and low stock price?

The 52-week high price of Vaxcyte Inc (PCVX) is $119.27. The 52-week low price of Vaxcyte Inc (PCVX) is $44.2.

What is Vaxcyte Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Vaxcyte Inc (PCVX) is

What is Vaxcyte Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Vaxcyte Inc (PCVX) is 4.54

What is Vaxcyte Inc dividend yield?

The dividend yield of Vaxcyte Inc (PCVX) is 0.00%

What is the Market Cap of Vaxcyte Inc?

The market capitalization of Vaxcyte Inc (PCVX) is $12.29B

What is Vaxcyte Inc’s stock symbol?

The stock symbol (or ticker) of Vaxcyte Inc is PCVX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top